193 related articles for article (PubMed ID: 34755644)
21. Projected Number of People With Onchocerciasis-Loiasis Coinfection in Africa, 1995 to 2025.
Vinkeles Melchers NVS; Coffeng LE; Boussinesq M; Pedrique B; Pion SDS; Tekle AH; Zouré HGM; Wanji S; Remme JH; Stolk WA
Clin Infect Dis; 2020 May; 70(11):2281-2289. PubMed ID: 31304961
[TBL] [Abstract][Full Text] [Related]
22. Implementation of test-and-treat with doxycycline and temephos ground larviciding as alternative strategies for accelerating onchocerciasis elimination in an area of loiasis co-endemicity: the COUNTDOWN consortium multi-disciplinary study protocol.
Wanji S; Nji TM; Hamill L; Dean L; Ozano K; Njouendou AJ; Abong RA; Obie ED; Amuam A; Ekanya R; Ndongmo WPC; Ndzeshang BL; Fung EG; Nnamdi DB; Nkimbeng DA; Teghen S; Kah E; Piotrowski H; Forrer A; Khan JAM; Woode ME; Niessen L; Watson V; Njoumemi Z; Murdoch ME; Thomson R; Theobald S; Enyong P; Turner JD; Taylor MJ
Parasit Vectors; 2019 Dec; 12(1):574. PubMed ID: 31801631
[TBL] [Abstract][Full Text] [Related]
23. Feasibility of Onchocerciasis Elimination Using a "Test-and-not-treat" Strategy in Loa loa Co-endemic Areas.
Blok DJ; Kamgno J; Pion SD; Nana-Djeunga HC; Niamsi-Emalio Y; Chesnais CB; Mackenzie CD; Klion AD; Fletcher DA; Nutman TB; de Vlas SJ; Boussinesq M; Stolk WA
Clin Infect Dis; 2021 Jun; 72(12):e1047-e1055. PubMed ID: 33289025
[TBL] [Abstract][Full Text] [Related]
24. [Secondary effects of the treatment of hypermicrofilaremic loiasis using ivermectin].
Ducorps M; Gardon-Wendel N; Ranque S; Ndong W; Boussinesq M; Gardon J; Schneider D; Chippaux JP
Bull Soc Pathol Exot; 1995; 88(3):105-12. PubMed ID: 8555762
[TBL] [Abstract][Full Text] [Related]
25. Satellite mapping of Loa loa prevalence in relation to ivermectin use in west and central Africa.
Thomson MC; Obsomer V; Dunne M; Connor SJ; Molyneux DH
Lancet; 2000 Sep; 356(9235):1077-8. PubMed ID: 11009145
[TBL] [Abstract][Full Text] [Related]
26. Co-infection with Onchocerca volvulus and Loa loa microfilariae in central Cameroon: are these two species interacting?
Pion SD; Clarke P; Filipe JA; Kamgno J; Gardon J; Basáñez MG; Boussinesq M
Parasitology; 2006 Jun; 132(Pt 6):843-54. PubMed ID: 16469200
[TBL] [Abstract][Full Text] [Related]
27. Still mesoendemic onchocerciasis in two Cameroonian community-directed treatment with ivermectin projects despite more than 15 years of mass treatment.
Kamga GR; Dissak-Delon FN; Nana-Djeunga HC; Biholong BD; Mbigha-Ghogomu S; Souopgui J; Zoure HG; Boussinesq M; Kamgno J; Robert A
Parasit Vectors; 2016 Nov; 9(1):581. PubMed ID: 27842567
[TBL] [Abstract][Full Text] [Related]
28. Identifying co-endemic areas for major filarial infections in sub-Saharan Africa: seeking synergies and preventing severe adverse events during mass drug administration campaigns.
Cano J; Basáñez MG; O'Hanlon SJ; Tekle AH; Wanji S; Zouré HG; Rebollo MP; Pullan RL
Parasit Vectors; 2018 Jan; 11(1):70. PubMed ID: 29382363
[TBL] [Abstract][Full Text] [Related]
29. Prevalences of Loa loa microfilaraemia throughout the area endemic for the infection.
Boussinesq M; Gardon J
Ann Trop Med Parasitol; 1997 Sep; 91(6):573-89. PubMed ID: 9425360
[TBL] [Abstract][Full Text] [Related]
30. An Integrated District Mapping Strategy for Loiasis to Enable Safe Mass Treatment for Onchocerciasis in Gabon.
Ella SN; Ogoussan K; Gass K; Hundley L; Diggle PJ; Johnson O; Biamonte M; Atsame J
Am J Trop Med Hyg; 2021 Nov; 106(2):732-739. PubMed ID: 34781262
[TBL] [Abstract][Full Text] [Related]
31. Integrated rapid mapping of onchocerciasis and loiasis in the Democratic Republic of Congo: impact on control strategies.
Tekle AH; Zoure H; Wanji S; Leak S; Noma M; Remme JH; Amazigo U
Acta Trop; 2011 Sep; 120 Suppl 1():S81-90. PubMed ID: 20525531
[TBL] [Abstract][Full Text] [Related]
32. Evaluating post-treatment Loa loa microfilarial densities to classify serious adverse events caused by ivermectin: a retrospective analysis.
Boullé C; Chesnais CB; Kamgno J; Gardon J; Chippaux JP; Ranque S; Garcia A; Pion SD; Boussinesq M
Lancet Microbe; 2023 Feb; 4(2):e93-e101. PubMed ID: 36646105
[TBL] [Abstract][Full Text] [Related]
33. Macrofilaricidal activity after doxycycline only treatment of Onchocerca volvulus in an area of Loa loa co-endemicity: a randomized controlled trial.
Turner JD; Tendongfor N; Esum M; Johnston KL; Langley RS; Ford L; Faragher B; Specht S; Mand S; Hoerauf A; Enyong P; Wanji S; Taylor MJ
PLoS Negl Trop Dis; 2010 Apr; 4(4):e660. PubMed ID: 20405054
[TBL] [Abstract][Full Text] [Related]
34. Important progress towards elimination of onchocerciasis in the West Region of Cameroon.
Kamga GR; Dissak-Delon FN; Nana-Djeunga HC; Biholong BD; Ghogomu SM; Souopgui J; Kamgno J; Robert A
Parasit Vectors; 2017 Aug; 10(1):373. PubMed ID: 28774318
[TBL] [Abstract][Full Text] [Related]
35. Impact of repeated mass ivermectin administration using a community directed approach on
Amambo GN; Fombad FF; Chounna Ndongmo PW; Abong RA; Njouendou AJ; Beng AA; Nji TM; Esum ME; Fru-Cho J; Manuel R; Kebede D; Enyong PI; Hoerauf A; Koudou B; Bockarie M; Wanji S
Parasite Epidemiol Control; 2024 May; 25():e00343. PubMed ID: 38405181
[TBL] [Abstract][Full Text] [Related]
36. Repurposed automated handheld counter as a point-of-care tool to identify individuals 'at risk' of serious post-ivermectin encephalopathy.
Bennuru S; Pion SD; Kamgno J; Wanji S; Nutman TB
PLoS Negl Trop Dis; 2014 Sep; 8(9):e3180. PubMed ID: 25232954
[TBL] [Abstract][Full Text] [Related]
37. Prevalences of loiasis in Ondo state, Nigeria, as evaluated by the rapid assessment procedure for loiasis (RAPLOA).
Adeoye GO; Akinsanya B; Otubanjo AO; Ibidapo CA; Atalabi T; Okwuzu J; Adejai EO; Braide EI
Ann Trop Med Parasitol; 2008 Apr; 102(3):215-27. PubMed ID: 18348776
[TBL] [Abstract][Full Text] [Related]
38. Why onchocerciasis transmission persists after 15 annual ivermectin mass drug administrations in South-West Cameroon.
Forrer A; Wanji S; Obie ED; Nji TM; Hamill L; Ozano K; Piotrowski H; Dean L; Njouendou AJ; Ekanya R; Ndongmo WPC; Fung EG; Nnamdi DB; Abong RA; Beng AA; Eyong ME; Ndzeshang BL; Nkimbeng DA; Teghen S; Suireng A; Ashu EE; Kah E; Murdoch MM; Thomson R; Theobald S; Enyong P; Turner JD; Taylor MJ
BMJ Glob Health; 2021 Jan; 6(1):. PubMed ID: 33431378
[TBL] [Abstract][Full Text] [Related]
39. In Southern Nigeria
Emukah E; Rakers LJ; Kahansim B; Miri ES; Nwoke BEB; Griswold E; Saka Y; Anagbogu I; Davies E; Ityonzughul C; D'Ambrosio M; Bakalar M; Fletcher DA; Nutman T; Kamgno J; Richards FO
Am J Trop Med Hyg; 2018 Jul; 99(1):116-123. PubMed ID: 29761763
[TBL] [Abstract][Full Text] [Related]
40. Operationalization of the test and not treat strategy to accelerate the elimination of onchocerciasis and lymphatic filariasis in Central Africa.
Kamgno J; Nana-Djeunga HC; Pion SD; Chesnais CB; Klion AD; Mackenzie CD; Nutman TB; Boussinesq M
Int Health; 2018 Mar; 10(suppl_1):i49-i53. PubMed ID: 29471340
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
